Atlas Trials

Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

Clinical trial NCT06054217 · UNKNOWN

Trial details

NCT number
NCT06054217
Sponsor
Tarsus Pharmaceuticals, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Meibomian Gland DysfunctionDemodex Infestation of EyelidBlepharitisDemodectic Blepharitis
Start date
2023-08-01
Primary completion
2024-06-15
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.